Pfizer is pleased to announce that the MHRA has approved the reclassification of the well-established proton pump inhibitor (PPI) Nexium Control ® (esomeprazole), making it available for consumers to ...
Catalent has entered into an exclusive long-term supply agreement to produce Pfizer’s OTC proton-pump inhibitor for heartburn treatment, Nexium 24HR (esomeprazole), which is also marketed as Nexium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results